Document is current
Any future updates will be listed below
-
Authors
Mochizuki, Yusuke
Tazawa, Hiroshi https://orcid.org/0000-0003-4658-1050
Demiya, Koji
Kure, Miho
Kondo, Hiroya
Komatsubara, Tadashi
Sugiu, Kazuhisa
Hasei, Joe
Yoshida, Aki
Kunisada, Toshiyuki
Urata, Yasuo
Kagawa, Shunsuke
Ozaki, Toshifumi
Fujiwara, Toshiyoshi
-
Funding
Funding for this research was provided by:
The Ministry of Education, Science, and Culture, Japan (16H05416, 19H03731, 25293323, 16K10862, 15K10446, 18K15242, 16K10596, 19K16835)
- License Information
-
More Information
Article History
Received: 12 May 2020
Accepted: 19 October 2020
First Online: 5 November 2020
Compliance with ethical standards
:
: Y. Urata is President & CEO of Oncolys BioPharma, Inc. H. Tazawa and T. Fujiwara are consultants of Oncolys BioPharma, Inc. The other authors disclosed no potential conflicts of interest.
